{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:26:13Z","timestamp":1790717173897,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1136\/ard.2004.025858","type":"journal-article","created":{"date-parts":[[2004,9,2]],"date-time":"2004-09-02T20:12:55Z","timestamp":1094155975000},"page":"630-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis"],"prefix":"10.1016","volume":"64","author":[{"given":"B","family":"Ostendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Iking-Konert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.025858_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/jama.1964.03070150014003","article-title":"Clinical manifestations of systemic lupus erythematosus","volume":"190","author":"Dubois","year":"1964","journal-title":"JAMA"},{"key":"10.1136\/ard.2004.025858_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.10753","article-title":"Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging","volume":"48","author":"Ostendorf","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.025858_bib3","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2","article-title":"Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist","volume":"41","author":"Bresnihan","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.025858_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/art.1780370507","article-title":"Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis","volume":"37","author":"Firestein","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.025858_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10141","article-title":"Treatment of rheumatoid arthritis with anakinra a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate","volume":"46","author":"Cohen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.025858_bib6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/rheumatology\/36.12.1283","article-title":"Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus","volume":"36","author":"Sturfelt","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.025858_bib7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.025858_bib8","first-page":"541","volume":"10","author":"Vitali","year":"1992","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 1","key":"10.1136\/ard.2004.025858_bib9","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1177\/0961203396005001061","article-title":"The efficacy of antimalarials in systemic lupus erythematosus","author":"Nayak","year":"1996","journal-title":"Lupus"},{"key":"10.1136\/ard.2004.025858_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1191\/096120301666080831","article-title":"Methotrexate therapy in systemic lupus erythematosus","volume":"10","author":"Sato","year":"2001","journal-title":"Lupus"},{"key":"10.1136\/ard.2004.025858_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00393-003-0530-y","article-title":"TNF alpha-antagonists in collagen vascular disease","volume":"62","author":"Manger","year":"2003","journal-title":"Z Rheumatol"},{"key":"10.1136\/ard.2004.025858_bib12","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/1529-0131(200011)43:11<2381::AID-ANR1>3.0.CO;2-M","article-title":"Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies","volume":"43","author":"Pisetsky","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.025858_bib13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(02)09800-8","article-title":"Drug-induced systemic lupus erythematosus and TNF-alpha blockers","volume":"360","author":"Mohan","year":"2002","journal-title":"Lancet"},{"key":"10.1136\/ard.2004.025858_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P","article-title":"et al A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.","volume":"43","author":"Jiang","year":"2000","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724430574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724430574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.025858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:25:18Z","timestamp":1736123118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724430574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0003496724430574"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.025858","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.025858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}